Investors with a lot of money to spend have taken a bearish stance on GSK GSK.
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with GSK, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 8 options trades for GSK.
This isn't normal.
The overall sentiment of these big-money traders is split between 25% bullish and 50%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $67,906, and 7, calls, for a total amount of $382,107.
Projected Price Targets
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $37.0 and $45.0 for GSK, spanning the last three months.
Insights into Volume & Open Interest
In terms of liquidity and interest, the mean open interest for GSK options trades today is 2434.8 with a total volume of 6,311.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for GSK's big money trades within a strike price range of $37.0 to $45.0 over the last 30 days.
GSK 30-Day Option Volume & Interest Snapshot
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GSK | CALL | SWEEP | NEUTRAL | 01/16/26 | $2.35 | $2.1 | $2.35 | $45.00 | $82.2K | 570 | 355 |
| GSK | CALL | SWEEP | NEUTRAL | 01/16/26 | $2.25 | $2.2 | $2.25 | $45.00 | $79.8K | 570 | 1.3K |
| GSK | CALL | SWEEP | BEARISH | 01/16/26 | $2.3 | $2.25 | $2.25 | $45.00 | $74.2K | 570 | 1.9K |
| GSK | PUT | SWEEP | BULLISH | 11/15/24 | $1.55 | $1.45 | $1.45 | $38.00 | $67.9K | 337 | 500 |
| GSK | CALL | SWEEP | BEARISH | 10/11/24 | $2.15 | $1.85 | $1.85 | $39.00 | $60.1K | 4.0K | 1.2K |
About GSK
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
In light of the recent options history for GSK, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Present Market Standing of GSK
- With a volume of 19,701,072, the price of GSK is up 5.97% at $40.29.
- RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
- Next earnings are expected to be released in 21 days.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for GSK with Benzinga Pro for real-time alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
